Loading
Cibus, Inc. Stock: price and insider trades · United States
US·Mcap US$130.7M
No insider purchase over the last 90 days. The latest was filed 31 Aug 2021.
Cibus, Inc.: what insiders have been doing
Cibus, Inc. is a listed company. Filings by its managers are published through SEC (Form 4). From 18 October 2025 to 18 October 2026, the disclosure feed for Cibus, Inc. logged 20 filings by 10 insiders.
The flow runs one way only: 1 sale worth €5, from 1 insider, and no purchase. One trade stands out by size: a sale of €5 from Sauer Noel, disclosed on 18 March 2026.
For context, the typical company on the same exchange (median of 5,458 companies) published 22 filings over the same period, against 20 filings here. Our records for Cibus, Inc. go back to 2021, with 3 purchases and 59 sales on the open market in total. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists revenue at 3.6 m USD and net income at -127.1 m USD.
The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
In the same market, recent insider purchases at GameStop Corp. and Heico Corp also feature in our signals. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
155
Thresholds
n/a
Buy Volume
€137,711
3 ops. · all time
Sell Volume
€275,300
59 ops. · all time
Who traded when
BuySaleGerhard Prante51 sales
Noel Sauer1 sale
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 20,619 of 24,161 companies
26.6
score / 100
Value4
Quality50
FCF yld-39%
Earn yld-97%
EV/EBITDA·
ROE-223%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$1.71
Analyst consensus
3 analysts1.67/5
US$2.00Target US$14.33(+738%)US$25.00
Income statement
RevenueUS$3.6M
Gross profitUS$3.6M100% margin
EBITDA-US$90.8M-2494% margin
Net income-US$127.1M-3492.3% margin
Valuation
PER (forward)-2.7x
P/Book8.8x
Beta1.59
Balance sheet & cash
Market capUS$130.7M
Total debtUS$33M
Free Cash Flow-US$51.2M
Debt / Equity1934%
Profitability & ownership
ROE-223.2%
ROA-10.2%
% insiders26.1%
% institutions29.2%
Last declaration on 10 June 2026
Declarations155 total
894,309 sharesClass A Common StockSEC:0001615594-26-000045:0
64,748 shares0Class A Common StockSEC:0001615594-26-000041:0
64,748 shares0Class A Common StockSEC:0001615594-26-000034:0
64,748 shares0Class A Common StockSEC:0001615594-26-000040:0
195,000 shares0Class A Common StockSEC:0001615594-26-000025:0
57,000 shares0Class A Common StockSEC:0001615594-26-000027:0
57,000 shares0Class A Common StockSEC:0001615594-26-000026:0
57,000 shares0Class A Common StockSEC:0001615594-26-000028:0
38,000 shares0Class A Common StockSEC:0001615594-26-000029:0
57,000 shares0Class A Common StockSEC:0001615594-26-000031:0
16,112 shares@ US$1.85100.0% of flowClass A Common StockSEC:0001615594-26-000014:0
3,676 shares@ US$1.875.1% of flowClass A Common StockSEC:0001615594-26-000016:0
8,954 shares@ US$1.8220.4% of flowClass A Common StockSEC:0001615594-26-000015:0
3,695 shares@ US$1.83100.0% of flowClass A Common StockSEC:0001615594-26-000017:0
1,763 shares@ US$1.8499.8% of flowClass A Common StockSEC:0001615594-26-000018:0
4,795 shares@ US$2.32564.4% of flowClass A Common StockSEC:0001615594-26-000010:0
1,496 shares@ US$1.321.5% of flowClass A Common StockSEC:0001615594-26-000012:0
4 shares@ US$1.4850.2% of flowClass A Common StockSEC:0001615594-26-000011:0
666,666 shares@ US$1.50100.0% of flowClass A Common StockSEC:0001193125-26-034094:0
333,333 shares@ US$1.503.8% of flowClass A Common StockSEC:0001193125-26-034092:0
4,000,000 shares0.0% of flowClass A Common StockSEC:0000950170-25-084928:0
5,714,286 shares@ US$1.7579.5% of flowClass A Common StockSEC:0000950170-25-084320:0
32,490 shares0Class A Common StockSEC:0001615594-25-000075:0
32,490 shares0Class A Common StockSEC:0001615594-25-000074:0
11,750 shares0Class A Common StockSEC:0001615594-25-000051:0
25 of 155 declarations
About Cibus, Inc.
Cibus, Inc. is a biotechnology company focused on developing solutions for agriculture. It specializes in crop improvement through innovative methods.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
